BioXconomy is part of the Informa Connect Division of Informa PLC
Informa PLC
|
ABOUT US
|
INVESTOR RELATIONS
|
TALENT
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
About
Events
Advertise
Stay Updated
Stay Updated
Investment
Related Topics
VC/PE
Seed Funding
IPOs
Recent in
Investment
See All
Asian currency
Investment
Eyes on Asia: Ascentage’s IPO, Arrivent & Lepu, Sanofi approval, and more
Eyes on Asia: Ascentage’s IPO, Arrivent & Lepu, Sanofi approval, and more
by
Millie Nelson
Feb 3, 2025
4 Min Read
funding round on wooden blocks with dollars behind
Investment
The CAR-T promise: Umoja bags $100m in Series C financing
The CAR-T promise: Umoja bags $100m in Series C financing
by
Millie Nelson
Jan 28, 2025
2 Min Read
Innovation
Related Topics
Hubs
Academic Research
R&D Technology
Recent in
Innovation
See All
headshot of Janeé Pelletier, chief marketing officer at Learning Undefeated.
Partnering
‘Houston, we have a talent problem!’ TMC taps up next gen of biopharma experts
‘Houston, we have a talent problem!’ TMC taps up next gen of biopharma experts
by
Millie Nelson
Feb 6, 2025
2 Min Read
Asian currency
Investment
Eyes on Asia: Ascentage’s IPO, Arrivent & Lepu, Sanofi approval, and more
Eyes on Asia: Ascentage’s IPO, Arrivent & Lepu, Sanofi approval, and more
by
Millie Nelson
Feb 3, 2025
4 Min Read
Partnering
Related Topics
Licensing
M&A
Deals
Best Practices
Recent in
Partnering
See All
headshot of Janeé Pelletier, chief marketing officer at Learning Undefeated.
Partnering
‘Houston, we have a talent problem!’ TMC taps up next gen of biopharma experts
‘Houston, we have a talent problem!’ TMC taps up next gen of biopharma experts
by
Millie Nelson
Feb 6, 2025
2 Min Read
Asian currency
Investment
Eyes on Asia: Ascentage’s IPO, Arrivent & Lepu, Sanofi approval, and more
Eyes on Asia: Ascentage’s IPO, Arrivent & Lepu, Sanofi approval, and more
by
Millie Nelson
Feb 3, 2025
4 Min Read
Business Strategy
Related Topics
Scaling/Commercialization
Growth Strategy
ESG
Outsourcing
Legal
Recent in
Business Strategy
See All
Hot keys for business analysis and commercialization
Scaling/Commercialization
A clear commercialization strategy is imperative for success, says expert
A clear commercialization strategy is imperative for success, says expert
by
Lisa Henderson
Jan 27, 2025
3 Min Read
the word deal written on blue blocks in white writing
Investment
JPM 2025: Gilead inks inflammatory deal with LEO
JPM 2025: Gilead inks inflammatory deal with LEO
by
Millie Nelson
Jan 20, 2025
2 Min Read
Home
LSX Events
LSX Events
Data
Innovation
To protect the future of healthcare, we need to be data-driven
To protect the future of healthcare, we need to be data-driven
by
Millie Nelson
Dec 4, 2024
2 Min Read
The ELA'S 2024
Innovation
LSX awards the crème de la crème of dealmaking
LSX awards the crème de la crème of dealmaking
by
Millie Nelson
Dec 3, 2024
2 Min Read
Investment
From Series A to B: Navigating the transition from promise to proof
From Series A to B: Navigating the transition from promise to proof
Nov 20, 2024
|
3 Min Read
by
Millie Nelson
, Editor
Partnering
Chiesi’s partnering success: Confessions of a mid-sized pharma
Chiesi’s partnering success: Confessions of a mid-sized pharma
Nov 14, 2024
|
6 Min Read
by
Lisa Henderson
Investment
Call for specific female health funding to tackle biotech finance gender gap
Call for specific female health funding to tackle biotech finance gender gap
Oct 30, 2024
|
2 Min Read
by
Millie Nelson
, Editor
Investment
What’s your secret sauce? VC’s on what makes a compelling pitch
VC’s on what makes a compelling pitch
Oct 24, 2024
|
3 Min Read
by
Millie Nelson
, Editor
Business Strategy
Build trust by making healthcare fairer and more equitable, say experts
Build trust by making healthcare fairer and more equitable, say experts
Oct 14, 2024
|
3 Min Read
by
Millie Nelson
, Editor
Investment
Trends in biotech investing: time to be cautiously optimistic
Mid-year 2024 trends in biotech investing
Sep 18, 2024
|
2 Min Read
Business Strategy
Building successful teams in biotech: “The future is female and very colorful”
Building successful teams in biotech
May 7, 2024
|
2 Min Read
by
Millie Nelson
, Editor
Innovation
GSK, Novartis, Calliditas among winners at LSX Awards
GSK, Novartis, Calliditas among winners at LSX Awards
Nov 16, 2023
|
3 Min Read
by
Millie Nelson
, Editor
BIO-EUROPE COVERAGE
Novo Nordisk sign
Business Strategy
Lessons and blessings: The Novo Nordisk way
Lessons and blessings: The Novo Nordisk way
Michael May, PhD, President, CCRM discusses Canada as a place for life sciences in this video.
Hubs
Bridging AI & Life Sciences, Why Investing in Canada Should Be Your Next Move
Bridging AI & Life Sciences, Why Investing in Canada Should Be Your Next Move
Shaking hands
Partnering
Picky pharma prone to better proven partners amid dealmaking downturn
Picky pharma prone to better proven partners amid dealmaking downturn
Hervé Ansanay, Biotech Alliance Manager, discusses the features of the RESEAU SATT - SATT NETWORK
Hubs
RESEAU SATT, the Best of French Deep Tech
RESEAU SATT, the Best of French Deep Tech
Latest
headshot of Janeé Pelletier, chief marketing officer at Learning Undefeated.
Partnering
‘Houston, we have a talent problem!’ TMC taps up next gen of biopharma experts
‘Houston, we have a talent problem!’ TMC taps up next gen of biopharma experts
Asian currency
Investment
Eyes on Asia: Ascentage’s IPO, Arrivent & Lepu, Sanofi approval, and more
Eyes on Asia: Ascentage’s IPO, Arrivent & Lepu, Sanofi approval, and more
Monika Paulė (Caszyme) and Dr Avencia Sánchez-Mejías (Integra Therapeutics) at BIO-Europe in Stockholm
Partnering
Partnerships underpin the CRISPR revolution, says Caszyme CEO
Partnerships underpin the CRISPR revolution, says Caszyme CEO
BIO-Europe Spring banner Milan Italy
Mar 17 - Mar 19, 2025
Mar 17 - Mar 19, 2025
Europe's Largest Springtime Biotech Partnering Event
REGISTER
Subscribe to Our Newsletters
Stay updated and receive your insights for life sciences investment, innovation and partnering directly in your inbox.
Stay Updated